α
AlphaSMO
/
→
Trv Gp Ii, LLC 13F Filing — Q3 2021 Positions | AlphaSMO
Trv Gp Ii, LLC
/
Q3 2021
Trv Gp Ii, LLC — Q3 2021 13F Holdings
CIK: 0001614073
Total reported value
$1.3M
← Back to latest quarter
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
JNCEEUR
Jounce Therapeutics INC
Stock-Other
88.84%
—
-39.34%
2
ALNAEUR
Allena Pharmaceuticals INC
Stock-Other
11.16%
—
—